Three medical researchers at the Children's Cancer and Hematology Center of the Los Angeles Children's Hospital (CHLA) received more than $ 1 million in grants from the St. Baldrick Foundation, the largest private funder of childhood cancer research. The funding will support research efforts covering both neuroblastoma and acute lymphoblastic leukemia - two of the most aggressive childhood cancers.
Michael Pulsipher, MD, director of the Blood and Bone Marrow Transplant Consortium (PBMTC), received ongoing support for ongoing work evaluating cellular and immunological approaches to prevent relapse in children with acute lymphoblastic leukemia.
Robert Seeger, MD, received a grant from the St. Baldrick Consortium to support the New Approaches to Neuroblastoma (NANT) consortium, which is headquartered at ABSC. The research, led by Seeger, aims to improve the immune system's ability to eliminate neuroblastoma by targeting both cancer cells and surrounding cells that help tumor cells grow and resist treatment. The work will allow the development of new therapies with the potential to improve the survival of children with high-risk neuroblastoma, the second most common solid tumor in children.
Muller Fabbri, MD, PhD, received a St. Baldrick Scholar Scholarship to study how genetics and immune cells affect the growth of neuroblastoma tumors. Fabbri is working on a new strategy to target immune cells that contribute to disease progression with a goal toward developing more powerful immunotherapies to improve outcomes for children with this disease.
"We are excited to be able to support these talented and dedicated researchers who are truly committed to improving outcomes for children with ALL and neuroblastoma," said Kathleen Ruddy, Executive Director of the St. Baldrick Foundation. "Dr. Seeger, Dr. Pulsipher and Dr. Fabbri are discovering new ways to make the patient's immune system work better against resistant cancers, which is simply incredible."
"S. Baldrick's continues to be an important partner in our cancer research program at CHLA and with their support, our team of investigators ushers in a new era of cancer immunotherapy. cancer, "said Alan S. Wayne, MD, director of the Children's Center Against Cancer and Blood Disease. "The foundation's support has helped our researchers conduct critical studies for large federal grants from the National Cancer Institute and the National Institutes of Health, dramatically improving the reach and impact of our childhood cancer research. »
Source:
https://www.chla.org/press-release/chla-awarded-more-1-million-from-st-baldrick-s-foundation -fund-cancer-research
ed983f9f-ff53-4359-ab21-520978ee1fe9 | 0 | .0
Posted in: Children's Health News | News of medical research | Medical Conditions News
[ad_2]
Source link